SAI MedPartners Enhances Its Competitive Intelligence Capabilities Through the Acquisition of The Dunn Group

Audio By Carbonatix

READING, Pa.--(BUSINESS WIRE)--Dec 4, 2025--

SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired The Dunn Group (“TDG”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022.

TDG, headquartered in Totowa, NJ, is a competitive intelligence firm that focuses on providing primary business intelligence to clients in the pharmaceutical and biotechnology industries. TDG delivers competitive landscape insights by analyzing pipelines, tracking therapy areas, and conducting analogue assessments. The acquisition of TDG will enhance SAI’s core competitive intelligence offering.

“We are excited to welcome the Dunn Group to the SAI platform. The Dunn Group has a longstanding legacy in providing competitive intelligence services to the healthcare industry, and we look forward to working with Stu and his team to further deepen our relationships with our clients and continue to provide best-in-class services," stated Erik Nordhoy, Founder and CEO of SAI.

ABOUT SAI MEDPARTNERS

SAI is a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries. Headquartered in Reading, Pennsylvania, SAI provides best-in-class competitive intelligence and strategy support services to assist its clients across the product development lifecycle. SAI works with leading multinational pharmaceutical companies, in addition to a growing number of biotechnology and medical device companies. SAI has a presence across the United States, Europe, and Asia. For more information, please visit www.sai-med.com.

ABOUT NORTHLANE CAPITAL PARTNERS

Based in Bethesda, MD, NCP is a middle market private equity firm focused on key segments within the healthcare and business services sectors, where its principals have invested $1.8 billion of equity capital. NCP’s strategy is to partner with industry leading companies and great management teams, aligning incentives to accelerate growth and build value. For more information, please visit www.northlanecapital.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251204484293/en/

CONTACT: SAI CONTACTErik Nordhoy, CEO

(610) 685-4204NCP CONTACTSEugene Krichevsky, Partner

(301) 841-1399JJ Carbonell, Partner

(301) 841-1420Anna Ellingboe, Vice President

(301) 272-9992

KEYWORD: PENNSYLVANIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MEDICAL DEVICES FINANCE CONSULTING BUSINESS PROFESSIONAL SERVICES BIOTECHNOLOGY HEALTH PHARMACEUTICAL GENERAL HEALTH

SOURCE: NORTHLANE CAPITAL PARTNERS

Copyright Business Wire 2025.

PUB: 12/04/2025 03:10 PM/DISC: 12/04/2025 03:10 PM

http://www.businesswire.com/news/home/20251204484293/en